Results 241 to 250 of about 286,275 (354)

The impact of accumulating immune adaptation in circulating strains of HIV‐1

open access: yesHIV Medicine, EarlyView.
Abstract Background Mutations in human immunodeficiency virus type 1 (HIV‐1) enable the virus to evade recognition and killing by human leucocyte antigen (HLA)‐restricted T cells. These viral adaptations are specific to the HLA type of individuals and are therefore evident as HLA allele‐HIV sequence associations at the population level. Most studies of
Marwah Al‐kaabi   +7 more
wiley   +1 more source

Prodrug strategies in developing antiviral nucleoside analogs. [PDF]

open access: yesRSC Med Chem
Suresh RR   +15 more
europepmc   +1 more source

Real‐world use of second‐generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS‐CO3‐AquiVIH‐NA cohort

open access: yesHIV Medicine, EarlyView.
Abstract Objectives To characterize real‐world treatment switching in France to bictegravir (BIC or B) or dolutegravir (DTG)‐based regimens with a focus on treatment persistence, effectiveness (HIV‐1 RNA ≤50 copies/ml) and particular attention to the prevalence and incidence of comorbidities. Methods People living with HIV from the prospective ANRS‐CO3‐
O. Leleux   +15 more
wiley   +1 more source

Prevalence of low‐level viremia and its association with virological failure among adolescents living with HIV in Eastern Cape, South Africa

open access: yesHIV Medicine, EarlyView.
Abstract Objectives Low‐level viremia (LLV) has been associated with an increased risk of virological failure among adults on antiretroviral therapy (ART). However, evidence on the clinical implications of LLV among adolescents living with HIV remains limited.
Zea Leon   +7 more
wiley   +1 more source

Genetic diversity and drug resistance mutations of HIV-1 in Ghana: a systematic review of two decades. [PDF]

open access: yesBMC Infect Dis
Appiah P   +12 more
europepmc   +1 more source

PYRIMIDINE NUCLEOSIDE ANTAGONISTS

open access: yesJournal of Biological Chemistry, 1951
T K, FUKUHARA, D W, VISSER
openaire   +2 more sources

A multidisciplinary, AI‐supported quality improvement intervention to manage polypharmacy in aging people with HIV

open access: yesHIV Medicine, EarlyView.
Abstract Objectives Aging people with HIV are increasingly affected by multimorbidity and polypharmacy, which heighten the risk of drug–drug interactions (DDIs) and potentially inappropriate medications (PIMs). This study evaluated a multidisciplinary, AI‐supported quality improvement intervention designed to optimize polypharmacy management in older ...
Jovana Milic   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy